Research article · 2015
Conference abstract
Robust generation of cardiomyocytes from human pluripotent stem cell-derived cardiovascular progenitor cells and direct conversion of heart fibroblasts
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Cardiovascular progenitor cells (CVPCs) derived from human pluripotent stem cells (hPSCs) offer great promise for the cell-based therapy of cardiovascular disease (CVD). Here we optimized the differentiation and maintenance conditions in a xeno- and feeder free manner and differentiated hPSCs, including human embryonic stem cell (hESC) lines (H1 and H9) and GMP grade human induced pluripotent stem cell (GMP-hiPSC), into CVPCs. These CVPCs have the ability to be stably and clonally expanded under a xeno- and feeder free manner in vitro. Furthermore, they have the potentials to generate cardiovascular trilineages including cardiomyocytes, smooth muscle cells and endothelial cells in vitro. In conclusion, we obtained the clinical-grade hPSC-derived CVPCs. Our strategies could provide an effective and safe source of cells for myocardial regenerative medicine in clinic. Also, recent data from our group and others has shown that manipulation of the genome of cells in murine hearts can result in direct conversion of these cells into CMs in situ. Using human fibroblasts and compounds that modulate the function of chromatin-modifying enzymes, we have successfully achieved up to 90-fold upregulation of CM structural genes following drug treatment. Moreover, using a similar approach, we have achieved highly efficient conversion to phenotypic endothelial cells as determined by flow cytometry and gene expression. The discovery of such small molecules would provide significant advantages compared to cell-based or gene-based therapies by circumventing commercialization and regulatory challenges.
Keywords
Subjects
Genetics & Molecular BiologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Similar by topic
Conference abstract
Direct conversion of pluripotent human embryonic stem cells into functional human neuronal or cardiomyocyte cell therapy derivatives for regenerative medicine
Research article · 2016
Direct Comparison of DNA versus mRNA on the Efficiency of Induced Pluripotent Stem Cells Generation from Human Primary Fibroblasts
Conference abstract · 15 Oct 2018
Migration, integration and differentiation of human induced pluripotent stem cell-derived otic progenitors following transplantation in animal model of sensorineural hearing loss
Editorial · 2020
Stem Cell Research 2018-Foxd1-Dependent and Independent Pathways for Reprogramming from Fibroblasts to Induced Pluripotent Stem Cells or Cardiomyocytes- Tasuku Tsukamoto- Ritsumeikan University
More from this journal
The newest in Journal of Stem Cell Research & Therapy.
Article · 2 Jun 2026
Stem Cell Therapy for Diabetes Mellitus: Exploring Cellular Approaches for Pancreatic Regeneration
Article · 2 Jun 2026
Stem Cell Banking and Preservation: Advancing Future Therapeutic Possibilities through Cellular Storage
Article · 2 Jun 2026
Stem Cells in Cardiovascular Regeneration: Emerging Strategies for Heart Repair and Functional Recovery
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Stem Cell Research & Therapy
- SubjectGenetics & Molecular Biology
- BylineArticles whose byline prints “Xianmei Meng”
- BylineArticles whose byline prints “Ben Van Handel”
- BylineArticles whose byline prints “Ali Nsair”

